Cargando…
Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase
Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were included in this prospective study. The incidence of primary end-point (CCS: complete clinical success, defined...
Autores principales: | Kiran, G. Ravi, Chandrasekhar, P., Mohammad Ali, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322749/ https://www.ncbi.nlm.nih.gov/pubmed/34154758 http://dx.doi.org/10.1016/j.ihj.2021.02.005 |
Ejemplares similares
-
Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis
por: Kathirvel, D., et al.
Publicado: (2018) -
Outcome of thrombolysis with streptokinase in patients with prosthetic valve thrombosis
por: Abbas, Shahid, et al.
Publicado: (2021) -
Efficacy and safety of streptokinase in prosthetic valve thrombosis (total 5 years clinical registry)
por: Sharma, Kamal H., et al.
Publicado: (2010) -
Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2017) -
Successful Fibrinolytic Therapy in a Challenging Obstructive Prosthetic Mitral Valve Thrombosis
por: Essa, Amr, et al.
Publicado: (2020)